PubMed:32736597 / 15-169
Annnotations
LitCovid-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 32-50 | CHEBI:5801 | denotes | hydroxychloroquine |
T2 | 32-50 | DG_20 | denotes | hydroxychloroquine |
T3 | 32-50 | CHEBI:5801 | denotes | hydroxychloroquine |
T4 | 123-134 | NCBITaxon:11118 | denotes | Coronavirus |
T5 | 144-152 | SP_7 | denotes | COVID-19 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 144-152 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-1 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T1 | 32-50 | Chemical | denotes | hydroxychloroquine | http://purl.obolibrary.org/obo/CHEBI_5801 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T2 | 0-154 | Sentence | denotes | A cluster-randomized study with hydroxychloroquine versus observational support for prevention or early-phase treatment of Coronavirus disease (COVID-19): |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
3 | 32-50 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
4 | 123-142 | Disease | denotes | Coronavirus disease | MESH:D018352 |
5 | 144-152 | Disease | denotes | COVID-19 | MESH:C000657245 |